-
failures of transformers as well as advancing the capability and safety of language agents. Responsibilities will include leading research projects, training graduate and undergraduate researchers, assisting
-
pigment cells, contribute to multi-organ health through functional diversification. We leverage our understanding of healthy melanocyte heterogeneity to uncover mechanistic explanations for the clinical
-
. These studies involve the clinical and pre-clinical development of novel anti-cancer therapies and novel drug combinations, as well as characterizing the mechanisms of resistance to FDA approved agents
-
, cellular, and genetic mechanisms underlying cardiovascular disease. The research emphasizes vascular biology, intracellular signaling, and the integration of multi-omic data to uncover therapeutic targets in
-
-based modeling, and multi-omics analytics, including bulk, single-cell, and spatial transcriptomics, to uncover molecular mechanisms in cancer, immunology, and more. With a strong translational focus, the
-
how individual melanocytes, commonly known as pigment cells, contribute to multi-organ health through functional diversification. We leverage our understanding of healthy melanocyte heterogeneity
-
expertise in immunology with multi-color flow cytometry, confocal microscopy, molecular biology techniques such as qPCR, Western blot analysis, experience analyzing large and complex data sets, and strong
-
in Dr. Shanlin Ke’s lab. The overarching goal of Dr. Ke’s lab is to develop computational approaches and leveraging bioinformatics tools, metagenomic sequencing, multi-omics data, machine learning, and
-
and cover crop maps over the entire CBW by leveraging multi-source remote sensing data (e.g., Landsat, Sentinel-2, WorldView3) and field observations Integrate the newly developed tillage and cover crop
-
methods, prospective cohort studies, clinical trials including single site pilots and large-scale multi-site clinical trials, and implementation science including implementation trials. An existing cancer